Canine otitis externa is a prevalent inflammatory condition affecting the external ear canal of dogs. It is a multifactorial disorder where bacterial and fungal pathogens, notably Pseudomonas ...

The US Food and Drug Administration (FDA) has approved Otonomy, Inc's Otiprio (ciprofloxacin otic suspension) 6% for the treatment of acute otitis externa (AOE) in patients 6 months of age and older ...

Background: Otitis externa has a lifetime prevalence of 10% and can arise in acute, chronic, and necrotizing forms. Methods: This review is based on publications retrieved by a selective search of the ...

The U.S. Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer's ear. Acute otitis externa is an ...

Otitis externa, also commonly referred as Swimmer’s Ear, is an inflammatory condition that affects the external ear canal, which is the passage that connects the eardrum to the outer visible ear. The ...

SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the ...

Swimmer's ear, or acute otitis externa (AOE), is an inflammation or infection of the external auditory canal that may or may not include the auricle. [1] It is a common health problem that is seen ...